Sagimet director Tim Walbert resigns; annual meeting ratifies board and auditor

Sagimet Biosciences Inc.

Tim Walbert resigned from Board effective June 12, 2026, citing other commitments, no disagreement.
All four Class III directors elected: Jarrett, Phillips, Happel, Kemble with 6.5M-8.8M votes for each.
KPMG LLP ratified as independent auditor for FY 2026: 19.1M for, 14k against.
Outstanding shares of Series A common stock: 32,017,613 as of record date April 17, 2026.

item 5.02 item 5.07

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Tim Walbert

Board Member

SGMT · Sagimet Biosciences Inc.

Effective: 2026-06-12
Filed: June 12, 2026, 4:06 PM ET

On June 12, 2026, Tim Walbert, a member of the Board of Directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”), tendered his resignation from the Board, effective as of June 12, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tim Walbert resigned as Board Member at Sagimet Biosciences Inc..

Action: resigned
Role: Board Member

Exact text from the filing

On June 12, 2026, Tim Walbert, a member of the Board of Directors (the “Board”) of Sagimet Biosciences Inc. (the “Company”), tendered his resignation from the Board, effective as of June 12, 2026.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sagimet Biosciences Inc. shareholders approved Election of Class III Directors at the 2026-06-12 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-12

Exact text from the filing

Each of Jennifer Jarrett, Anne Phillips, M.D., David Happel and George Kemble, Ph.D. were elected to the Board to serve as Class III directors until the 2029 Annual Meeting of Stockholders and until their successors, if any, are elected or appointed, or their earlier death, resignation, retirement, disqualification or removal, as follows: Name For Withheld Broker Non-Votes Jennifer Jarrett 6,461,429 2,555,268 10,124,106 Anne Phillips, M.D. 7,806,504 1,210,193 10,124,106 David Happel 8,753,884 262,813 10,124,106 George Kemble, Ph.D. 8,688,684 328,013 10,124,106

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sagimet Biosciences Inc. shareholders approved Ratification of Independent Registered Public Accountant at the 2026-06-12 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-12

Exact text from the filing

Proposal 2 - Ratification of Independent Registered Public Accountant . The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year was ratified, as follows: For Against Abstentions Broker Non-Votes 19,091,619 13,960 35,224 0

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Sagimet Biosciences Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-073431

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.